Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Baosheng Li
Observed names:
BAOSHENG LI,
Bao-Sheng Li
Institutions:
Tianjin Medical University Cancer Institute and Hospital,
Shandong Tumor Hospital,
Shandong First Medical University,
Tianjin Medical University
Observed institutions:
Shandong University,
Jilin University,
Tianjin Medical University Cancer Institute and Hospital,
Shandong Tumor Hospital,
Shandong First Medical University,
Tianjin Medical University
show all 6
ORCID:
0000-0002-1515-2918
Observed ORCID:
0000-0002-1515-2918
OpenAlex ID:
A5100701368
Gelatin Tight-Coated Poly(lactide-co-glycolide) Scaffold Incorporating rhBMP-2 for Bone Tissue Engineering
2015
·
Juan Wang
, Dongsong Li
, et al.
·
Materials
·
40
PDF
Efficacy of 3D conformal thoracic radiotherapy for extensive-stage small-cell lung cancer: A retrospective study
2015
·
ZUPENG LUAN
, ZHIWU WANG
, et al.
·
Experimental and Therapeutic Medicine
·
21
PDF
Comparison of once daily radiotherapy to 60 G y and twice daily radiotherapy to 45 G y for limited stage small‐cell lung cancer
2015
·
Dan Han
, Shaoyu Hao
, et al.
·
Thoracic Cancer
·
20
PDF
CYFRA21-1 can predict the sensitivity to chemoradiotherapy of non-small-cell lung carcinoma
2010
·
Juan Wang
, Yan Yi
, et al.
·
Biomarkers
·
20
A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinoma
2022
·
Ning Li
, Tao Wu
, et al.
·
BMC Medicine
·
16
PDF
A new risk score model based on lactate dehydrogenase for predicting prognosis in esophageal squamous cell carcinoma treated with chemoradiotherapy
2023
·
Chengxin Liu
, Jinmin Han
, et al.
·
Journal of Thoracic Disease
·
11
PDF
Twice-daily thoracic radiotherapy by intensity-modulated radiation therapy (IMRT) compared with simultaneous integrated boost IMRT (SIB-IMRT) with concurrent chemotherapy for patients with limited-stage small cell lung cancer. A propensity-score matched analysis
2022
·
Hongfu Sun
, Chengxin Liu
, et al.
·
Radiotherapy and Oncology
·
8
Tumor suppressor candidate 3 as a novel predictor for lymph node metastasis in lung cancer patients
2016
·
Xinshuang Yu
, Kaixian Zhang
, et al.
·
Oncology Letters
·
8
PDF
Neoadjuvant radiation target volume definition in esophageal squamous cell cancer: a multicenter recommendations from Chinese experts
2024
·
Dan Han
, jinling Dong
, et al.
·
BMC Cancer
·
7
PDF
The Assessment of Volumetric Changes for Alveolar Ridge Preservation or Reconstruction by Three-dimensional Analysis at Posterior Extraction Sites with Severe Bone Defects Using DBBM-C Collagen Membrane and PRF: A Prospective and Randomized Clinical Trial
2024
·
Haina Yu
, Qing Cai
, et al.
·
The International Journal of Periodontics & Restorative Dentistry
·
6
Comparison of long-term survival between temozolomide-based chemoradiotherapy and radiotherapy alone for patients with low-grade gliomas after surgical resection
2016
·
Xiu-juan Gai
, Yumei Wei
, et al.
·
OncoTargets and Therapy
·
6
PDF
Chinese expert consensus on the application of pegylated recombinant human granulocyte colony‐stimulating factor during concurrent chemoradiotherapy (2020 edition)
2021
·
Jun Wang
, Baosheng Li
·
Precision Radiation Oncology
·
5
PDF
Clinical significance of serum soluble death receptor 5 concentration in locally advanced non-small cell lung cancer patients
2014
·
XINSHUANG YU
, JUAN DU
, et al.
·
Oncology Letters
·
3
PDF
Stereotactic body radiation therapy for early-stage non-small cell lung cancer: a single-institutional retrospective analysis of outcomes and prognostic factors
2025
·
Chengrui Fu
, Jigang Dong
, et al.
·
Frontiers in Oncology
·
1
PDF
Multi-task and multi-scale attention network for lymph node metastasis prediction in esophageal cancer
2025
·
Yan Yi
, Jiacheng Wang
, et al.
·
Medical & Biological Engineering & Computing
·
1
Preliminary results of the ALTER-E009 study: Efficacy and safety of anlotinib combined with radiotherapy in patients with locally advanced or metastatic esophageal squamous cell carcinoma (ESCC)—A multicenter, multi-cohort retrospective exploratory study.
2025
·
Xin Wang
, Guojie Feng
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Plus Thoracic Radiotherapy Improves Survival in Patients with Epidermal Growth Factor Receptor-Mutated Stage IV Non-Small Cell Lung Cancer
2024
·
Xinhang Gu
, Jiaxiao Geng
, et al.
·
Research Square
·
1
Update results of paclitaxel and cisplatin in combination with anlotinib as first-line regimen for patients with advanced ESCC: A multicenter, single-arm, open-label phase Ⅱ clinical trial.
2022
·
Junsheng Wang
, Tao Wu
, et al.
·
Journal of Clinical Oncology
·
1
Update results of paclitaxel and cisplatin in combination with anlotinib as first-line regimen for patients with advanced ESCC: A multicenter, single-arm, open-label phase Ⅱ clinical trial.
2021
·
Junsheng Wang
, Tao Wu
, et al.
·
Journal of Clinical Oncology
·
1
Clinical observation of prophylactic use of pegylated recombinant human granulocyte stimulating factor in breast cancer patients with postoperative radiotherapy
2020
·
Yanfang Du
, Fan Yan-ling
, et al.
·
Guoji zhongliuxue zazhi
·
1
Effect, safety, timing and dose of thoracic radiotherapy plus third-generation EGFR-TKIs as first-line treatment in patients with EGFR-mutated oligo-organ metastatic NSCLC
2025
·
Xinhang Gu
, Jiaxiao Geng
, et al.
·
Frontiers in Oncology
PDF
Updated results of the ALTER-E00 study: Efficacy and safety of anlotinib combined with radiotherapy in patients with locally advanced or metastatic esophageal squamous cell carcinoma (ESCC): A multi-center, multi-cohort retrospective exploratory study.
2025
·
Xin Wang
, Guojie Feng
, et al.
·
Journal of Clinical Oncology
PDF
419: surgery versus radiotherapy for limited-stage small cell esophageal carcinoma: a multicenter study
2024
·
Jie Zhu
, Yi Wang
, et al.
·
Radiotherapy and Oncology
Updated results of paclitaxel and cisplatin in combination with anlotinib as first-line treatment for patients with advanced ESCC: A multicenter, single-arm, open-label phase II clinical trial.
2023
·
Ning Li
, Tao Wu
, et al.
·
Journal of Clinical Oncology
Alveolar Ridge Reconstruction or Augmentation at Posterior Extraction Sites with Severe Bone Defect Using DBBM-C Collagen Membrane and PRF. A Randomized Clinical Trial
2022
·
Haina Yu
, Qing Cai
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
28
Citation count:
178
H-index:
8
I10-index:
6
Year
Topic
Type